Safety and Efficacy of Left Atrial Appendage Occlusion Devices

Completed

Conditions studied: Atrial Fibrillation

In brief

Atrial fibrillation (AF) is the most common cardiac rhythm disorder in clinical practice. In the last two decades the number of hospitalizations for AF has increased two- to three-fold. More than 6 million people worldwide suffer from atrial fibrillation (AF), a cardiac disorder that results in systemic emboli. Patients with AF are 5 times more likely to have a stroke compared with those without AF. This registry will collection information on two devices that are used to treat AF. The WATCHMAN and LARIAT. The differences in techniques and subsequent effects of the two devices on outcomes related to AF has not been studied. This study will look to compare the two devices to see how the outcomes may vary.

Key facts

Study ID

NCT01695564

Run by

Kansas City Heart Rhythm Institute

People needed

169

Starts

2012-05-01

Expected to finish

2018-02-01

Last updated by the study team

2019-05-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who have had a LARIAT LAA device occlusion

You may not qualify if…

• Patients who have PFO/ASD/critical carotid artery (>70% blockage) disease and hemorrhagic strokes

Where it is running

• University of Kansas Medical Center — Kansas City, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.